The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This stock page is the Follow view. The Build view lets your agent query PALI owners, fund changes, insider filings, and source links through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/PALI"
Use Arkolith to show who owns PALI, which funds added or reduced it, and which SEC filings prove each claim.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | B Group, Inc. | $20.0M | 11.4M | ▲+154% Added · +6.9M sh | Q1 2026 | |
| 2 | JANUS HENDERSON GROUP PLC | $18.8M | 10.7M | ▲+1.4% Added · +149K sh | Q1 2026 | |
| 3 | PERCEPTIVE ADVISORS LLC | $15.6M | 8.9M | ▼−26% Reduced · −3.1M sh | Q1 2026 | |
| 4 | AMERIPRISE FINANCIAL INC | $15.2M | 8.7M | ▲+26% Added · +1.8M sh | Q1 2026 | |
| 5 | Commodore Capital LP | $12.6M | 7.2M | ▼−37% Reduced · −4.3M sh | Q1 2026 | |
| 6 | RA CAPITAL MANAGEMENT, L.P. | $12.5M | 7.1M | —Held | Q1 2026 | |
| 7 | FRANKLIN RESOURCES INC | $10.1M | 5.8M | ▲+14% Added · +693K sh | Q1 2026 | |
| 8 | GOLDMAN SACHS GROUP INC | $9.4M | 5.4M | ▲+864% Added · +4.8M sh | Q1 2026 | |
| 9 | Eversept Partners, LP | $8.7M | 5.0M | ▼−7.5% Reduced · −404K sh | Q1 2026 | |
| 10 | Boxer Capital Management, LLC | $8.4M | 4.8M | —Held | Q1 2026 | |
| 11 | MORGAN STANLEY | $8.0M | 4.6M | ▲+9.9% Added · +409K sh | Q1 2026 | |
| 12 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $7.9M | 4.5M | —Held | Q1 2026 | |
| 13 | BALYASNY ASSET MANAGEMENT L.P. | $5.7M | 3.3M | ▲10× Added · +2.9M sh | Q1 2026 | |
| 14 | FEDERATED HERMES, INC. | $5.5M | 3.1M | ▲New +3.1M sh | Q1 2026 | |
| 15 | VANGUARD GROUP INC | $5.0M | 2.1M | ▲New +2.1M sh | Q4 2025 | |
| 16 | MARSHALL WACE, LLP | $4.8M | 2.8M | ▲New +2.8M sh | Q1 2026 | |
| 17 | Vestal Point Capital, LP | $4.4M | 2.5M | ▲New +2.5M sh | Q1 2026 | |
| 18 | ORBIMED ADVISORS LLC | $4.1M | 2.3M | ▲+25% Added · +462K sh | Q1 2026 | |
| 19 | ADAR1 Capital Management, LLC | $4.0M | 2.3M | ▲+13% Added · +260K sh | Q1 2026 | |
| 20 | MILLENNIUM MANAGEMENT LLC | $3.7M | 2.1M | ▲+614% Added · +1.8M sh | Q1 2026 | |
| 21 | Artia Global Partners LP | $3.5M | 2.0M | —Held | Q1 2026 | |
| 22 | BlackRock, Inc. | $3.3M | 1.9M | ▼−0.1% Reduced · −3K sh | Q1 2026 | |
| 23 | GEODE CAPITAL MANAGEMENT, LLC | $2.7M | 1.5M | ▼−1.2% Reduced · −19K sh | Q1 2026 | |
| 24 | RENAISSANCE TECHNOLOGIES LLC | $2.5M | 1.5M | ▼−39% Reduced · −928K sh | Q1 2026 | |
| 25 | VANGUARD CAPITAL MANAGEMENT LLC | $2.5M | 1.4M | ▲New +1.4M sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 10, 2026 | Wei Binxian | Director | Grant (A) | 592K | — |
| Jun 10, 2026 | Zwick Jordan Michael | Director | Grant (A) | 337K | — |
| Jun 10, 2026 | Wei Binxian | Director | Option exercise (M) | 20K | — |
| Jun 10, 2026 | Wei Binxian | Director | Option exercise (M) | 20K | $0 |
| Jun 10, 2026 | Williams Donald Allen | Director | Grant (A) | 1.5M | — |
| Jun 10, 2026 | Williams Donald Allen | Director | Option exercise (M) | 61K | — |
| Jun 10, 2026 | Williams Donald Allen | Director | Option exercise (M) | 61K | $0 |
| Jun 10, 2026 | Chuang Emil | Director | Grant (A) | 592K | — |
| Jun 10, 2026 | Chuang Emil | Director | Option exercise (M) | 20K | — |
| Jun 10, 2026 | Chuang Emil | Director | Option exercise (M) | 20K | $0 |
| Feb 12, 2026 | Jones Mitchell Lawrence | Chief Medical Officer | Sell (S) | 2K | $3K |
| Feb 12, 2026 | Finley John David | CEO, CFO, Director | Sell (S) | 4K | $7K |
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 19 funds | $1.7B |
| BOSTON SCIENTIFIC CORPBSX | 19 funds | $1.5B |
| INTUITIVE SURGICAL INCISRG | 19 funds | $1.3B |
| REGENERON PHARMACEUTICALSREGN | 19 funds | $210.4M |
| GILEAD SCIENCES INCGILD | 18 funds | $785.6M |
| BRISTOL-MYERS SQUIBB COBMY | 18 funds | $382.1M |
| BIOGEN INCBIIB | 18 funds | $272.8M |
| MASTERCARD INC - AMA | 17 funds | $1.8B |
| UNITEDHEALTH GROUP INCUNH | 17 funds | $1.5B |
| PALANTIR TECHNOLOGIES INC-APLTR | 17 funds | $1.2B |
| MERCK & CO. INC.MRK | 17 funds | $1.0B |
| EXXON MOBIL CORPXOM | 17 funds | $741.7M |
Ranked by how many of PALI's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for PALI. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.